concept

L-DOPA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about L-DOPA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

43Connections

0Hypotheses

0Analyses

19Outgoing

24Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	L-DOPA
Key Genes/Proteins	ALPHA-SYNUCLEIN, BDNF, DDC, DRD2, GDNF
Related Diseases	CEREBROSPINAL FLUID, DOPAMINE, OXIDATIVE STRESS, PARKINSON, PARKINSON'S DISEASE

Pathway Diagram

graph TD
    L_DOPA[L-DOPA]
    L_DOPA -->|involved_in| Dopamine_Synthesis[Dopamine Synthesis]
    L_DOPA -->|treats| Parkinson_s_Disease[Parkinson's Disease]
    L_DOPA -.protects against.-> DRD2[DRD2]
    L_DOPA -->|treats| PARKINSON_S_DISEASE[PARKINSON'S DISEASE]
    L_DOPA -->|produces| NEURONS[NEURONS]
    L_DOPA -->|inhibits| DOPAMINE[DOPAMINE]
    L_DOPA -->|expressed in| INTERNEURONS[INTERNEURONS]
    TH[TH] -->|regulates| L_DOPA
    SUBSTANTIA_NIGRA[SUBSTANTIA NIGRA] -->|inhibits| L_DOPA
    OXIDATIVE_STRESS[OXIDATIVE STRESS] -->|activates| L_DOPA
    DRD2 -->|treats| L_DOPA
    DDC[DDC] -->|converts| L_DOPA
    NEURONS -->|converts| L_DOPA

Outgoing (19)

Target	Relation	Type	Str
Parkinson's Disease	treats	disease	0.90
Dopamine Synthesis	involved_in	process	0.90
DRD2	protects_against	gene	0.70
PARKINSON'S DISEASE	treats	disease	0.65
DOPAMINE	inhibits	phenotype	0.65
NEURONS	associated_with	cell_type	0.65
INTERNEURONS	expressed_in	cell_type	0.60
DOPAMINE	stabilizes	phenotype	0.60
DDC	associated_with	gene	0.50
NEURON	associated_with	cell_type	0.50
STROKE	associated_with	disease	0.50
BDNF	associated_with	gene	0.50
GDNF	associated_with	gene	0.50
VEGF	associated_with	gene	0.45
TH	associated_with	gene	0.45
SEROTONIN	associated_with	phenotype	0.45
PARKINSON'S DISEASE	associated_with	disease	0.45
PARKINSON	associated_with	disease	0.45
DRD2	associated_with	gene	0.45

Incoming (24)

Source	Relation	Type	Str
TPL	associated_with	protein	0.95
TH	activates	gene	0.70
OXIDATIVE STRESS	activates	phenotype	0.70
TH	regulates	gene	0.70
TH	causes	gene	0.70
SUBSTANTIA NIGRA	inhibits	brain_region	0.70
DRD2	treats	gene	0.65
PARKINSON'S DISEASE	stabilizes	disease	0.60
NEURONS	associated_with	cell_type	0.60
TH	converts	gene	0.60
TH	stabilizes	gene	0.60
DDC	converts	gene	0.60
CEREBROSPINAL FLUID	associated_with	phenotype	0.50
INTERNEURONS	associated_with	cell_type	0.50
WHITE MATTER	associated_with	brain_region	0.50
SUBSTANTIA NIGRA	associated_with	brain_region	0.50
OXIDATIVE STRESS	associated_with	phenotype	0.50
ALPHA-SYNUCLEIN	associated_with	protein	0.50
PARKINSON	associated_with	disease	0.45
DOPAMINERGIC NEURONS	associated_with	cell_type	0.45
DRD2	associated_with	gene	0.45
DOPAMINE	associated_with	phenotype	0.45
SEROTONIN	associated_with	phenotype	0.45
PARKINSON'S DISEASE	associated_with	disease	0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning L-DOPA in their description or question text

No additional research found